We’ve recently conducted an industry-wide survey to understand how the community can accelerate injectable device developments.
Survey respondents include both large pharma and small biotech organizations, spanning across departments from formulation to regulatory affairs, from device development to manufacturing.
Take a look at what your peers think about the major hurdles and areas of most growth in this space.
Enjoy key insights on the following topics:
Combination Products: Dealing with Global Regulations
By John Smith, Director, Global, Regulatory Affairs, Allergan
Device Requirements for Injection Devices to Safeguard Compliance in Global Regions
By Gopi Vudathala, Head, Regulatory Affairs CMC & Compliance, GSK Vaccines
Enjoy this exclusive interview to gain key insights from Shannon Clark, CEO, UserWise, Inc., a specialist in human factors risk assessment and use-related risk analysis.
“It’s important to do a usability study as soon as a device is identified and developed – this helps you to recognize any design flaws that require improvement…save your organization a tremendous amount of effort, time and costs! “